Merck & Co., Inc. (MRK) Return on equity 2016–2025
Merck & Co., Inc. (MRK) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
34.7%FY2025 · since FY2016: 9.8% → 34.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 34.7% | -2.3 pp |
| FY2024 | 37.0% | +36.0 pp |
| FY2023 | 1.0% | -30.6 pp |
| FY2022 | 31.6% | -0.8 pp |
| FY2021 | 32.3% | +4.4 pp |
| FY2020 | 27.9% | -10.1 pp |
| FY2019 | 38.0% | +14.7 pp |
| FY2018 | 23.3% | +16.3 pp |
| FY2017 | 7.0% | -2.8 pp |
| FY2016 | 9.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice